Increased HRD score in cisplatin resistant penile cancer cells

Increased HRD score in cisplatin resistant penile cancer cells

Abstract Background/Introduction Penile cancer is a rare disease in demand for new therapeutic options. Frequently used combination chemotherapy with 5 fluorouracil (5-FU) and cisplatin (CDDP) in patients with metastatic penile cancer mostly results in the development of acquired drug resistance. Av...

Full description

Bibliographic Details
Main Authors: Ria Winkelmann, Katrin Bankov, Claudia Döring, Jaroslav Cinatl, Sebastian Grothe, Florian Rothweiler, Martin Michaelis, Christina Schmitt, Peter J. Wild, Melanie Demes, Jindrich Cinatl, Stefan Vallo
Format: Article
Language:English
Published: BMC 2022-12-01
Series:BMC Cancer
Subjects:
Penile carcinomas
Cell lines
Chemoresistance
Homologous recombination deficiency
Online Access:https://doi.org/10.1186/s12885-022-10432-7

Internet

https://doi.org/10.1186/s12885-022-10432-7

Similar Items